Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

43.19

+0.20 (0.47%)

At close: Mar 28, 2025, 4:00 PM

44.47

+1.28 (2.97%)

After-hours: Mar 28, 2025, 5:20 PM EDT

Cytokinetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Operating Revenue	18.47	7.53	7.59	70.43	55.83	Upgrade
Other Revenue	-	-	87	-	-	Upgrade
Revenue	18.47	7.53	94.59	70.43	55.83	Upgrade
Revenue Growth (YoY)	145.34%	-92.04%	34.30%	26.15%	107.79%	Upgrade
Cost of Revenue	339.41	330.12	240.81	159.94	96.95	Upgrade
Gross Profit	-320.93	-322.59	-146.23	-89.51	-41.12	Upgrade
Selling, General & Admin	215.31	173.61	177.98	96.8	52.82	Upgrade
Operating Expenses	215.31	173.61	177.98	96.8	52.82	Upgrade
Operating Income	-536.25	-496.21	-324.2	-186.31	-93.94	Upgrade
Interest Expense	-86.51	-57.67	-51.16	-29.33	-38.68	Upgrade
Interest & Investment Income	51.53	27.63	11.34	0.33	5.33	Upgrade
Other Non Operating Income (Expenses)	-18.3	-	-	-	-	Upgrade
EBT Excluding Unusual Items	-589.53	-526.24	-364.02	-215.31	-127.29	Upgrade
Other Unusual Items	-	-	-24.94	-	-	Upgrade
Pretax Income	-589.53	-526.24	-388.96	-215.31	-127.29	Upgrade
Net Income	-589.53	-526.24	-388.96	-215.31	-127.29	Upgrade
Net Income to Common	-589.53	-526.24	-388.96	-215.31	-127.29	Upgrade
Shares Outstanding (Basic)	112	97	90	77	65	Upgrade
Shares Outstanding (Diluted)	112	97	90	77	65	Upgrade
Shares Change (YoY)	16.01%	7.46%	16.83%	19.16%	12.07%	Upgrade
EPS (Basic)	-5.26	-5.45	-4.33	-2.80	-1.97	Upgrade
EPS (Diluted)	-5.26	-5.45	-4.33	-2.80	-1.97	Upgrade
Free Cash Flow	-399.8	-415.75	-310.85	-191.39	-2.11	Upgrade
Free Cash Flow Per Share	-3.57	-4.31	-3.46	-2.49	-0.03	Upgrade
Gross Margin	-	-	-154.59%	-127.09%	-73.66%	Upgrade
Operating Margin	-2902.72%	-6589.71%	-342.75%	-264.54%	-168.27%	Upgrade
Profit Margin	-3191.11%	-6988.63%	-411.21%	-305.72%	-228.00%	Upgrade
Free Cash Flow Margin	-2164.10%	-5521.23%	-328.64%	-271.76%	-3.78%	Upgrade
EBITDA	-526.72	-484.31	-318.39	-184.04	-92.11	Upgrade
EBITDA Margin	-	-	-	-261.31%	-164.99%	Upgrade
D&A For EBITDA	9.53	11.89	5.81	2.28	1.83	Upgrade
EBIT	-536.25	-496.21	-324.2	-186.31	-93.94	Upgrade
EBIT Margin	-	-	-	-264.54%	-168.27%	Upgrade
Revenue as Reported	18.47	7.53	94.59	70.43	55.83	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q